Legal Opinion
United States ex rel. Coyne v. Amgen, Inc.
District Court, E.D. New York
Decided January 17, 2017No. CV 12-3881 (JMA)(AYS)PublishedCited by 5 opinions
1Opinion of the Court
REPORT AND RECOMMENDATION
SHIELDS, Magistrate Judge:
This case was commenced as a qui tarn action pursuant to the Federal False Claims Act, 31 U.S.C. § 3729 (the “FCA”). Plaintiff Daniel Coyne, M.D. (“Coyne” or “Plaintiff’) brought the action as relator, seeking to represent the interests of the United States of America (the “United States”), the District of Columbia, and twenty-nine States (collectively the “Governmental Entities”). The case was commenced on August 6, 2012. See Docket Entry herein (“DE”) 1. The presently operative amended complaint (the “Amended Complaint”) was filed on…
2Cases cited31 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Thomas v. ArnSupreme Court of the United States · 1986
- Chambers v. Time Warner, Inc.Court of Appeals for the Second Circuit · 2002
- Arista Records, LLC v. Doe 3Court of Appeals for the Second Circuit · 2010
26 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- United States ex rel. Patriarca v. Siemens Healthcare Diagnostics, Inc.District Court, E.D. New York · 2018
- Maharaj v. The Estate of Charles Howard ZimmermanDistrict Court, D. Maryland · 2019
- Maharaj v. The Estate of Charles Howard ZimmermanDistrict Court, D. Maryland · 2020
- Scott v. The United States of AmericaDistrict Court, W.D. New York · 2023
- United States v. StrockDistrict Court, W.D. New York · 2019